Alcon AG Return on Equity

Alcon AG posts a ROE of 2.96%. That is above the Healthcare sector average of -75.84%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For Healthcare stocks, a ROE near -75.84% is typical. Alcon AG's 2.96% is higher that level. That is roughly 103.9% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Alcon AG's ROE moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 2.96%; use YoY and peer views to separate noise from signal.

Context for 0A0D.IL's ROE usually means three checks: (1) trend versus prior periods, (2) level versus peers (average -75.84%), and (3) consistency with growth and profitability. This page covers the first two; Alcon AG's other metric pages and overview cover the third.

Judging Alcon AG against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in ROE easier to interpret. Start with 2.96% here, then scan peer and history charts to see if the gap is persistent.